PHAT
Phathom Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.50
+4.97%Leverage
- Debt / equity
- -0.49x
- Net debt / equity
- 0.04x
- Debt / assets
- 0.51x
- Debt / EBITDA
- -4.76x
- Net debt / EBITDA
- 0.44x
Liquidity & coverage
- Current ratio
- 1.92x
- Quick ratio
- 1.87x
- Cash ratio
- 1.19x
- Interest coverage
- -0.64x
- EBITDA / interest
- -0.55x
- Working capital
- $142.1M
Cash & dividend
- FCF / debt
- -0.22x
- Cash flow / debt
- -0.22x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026